Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures - a Multicenter Randomized Controlled Trial

NCT00736684 is registered in ClinicalTrials.gov with AO Clinical Investigation and Publishing Documentation as lead sponsor.

NCT NCT00736684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures - a Multicenter Randomized Controlled Trial
Lead sponsor
AO Clinical Investigation and Publishing Documentation
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
September 30, 2010
Enrollment
440 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

unstable trochanteric fractures